The ketogenic diet, which lowers carbohydrates and increases fat intake, has become popular for weight loss. Although they offer some benefits, recent research has reveal that there could be detrimental side-effects, especially in the form of cardiovascular disease, caused by heightened levels of cholesterol.
What Does The Science Say About The Benefits?
There’s a lot of debate surrounding the now infamous keto diet which, unfortunately, doesn’t lay its groundwork in actually definitive science. Anecdotally, a lot of people have said that following the ketogenic diet has helped them gain increased energy levels, however, no research studies conducted on human have been able to prove this yet.
But on the other hand, it doesn’t mean that the diet is entirely ineffective, as it has been shown that it plays a substantive role in the fight against childhood epilepsy and could even show a little promise in delaying neurological disorders and cancer. However, long-term effects have not been established, which worries health professionals.
Cell-Aging Caused By A Ketogenic Diet
A new study published in the journal Science Advances examines the effects of a keto diet on cell aging in mice. Cellular senescence occurs when cells no longer divide but slow down, causing cells to clump together and cause disease. Studies have shown increased signs of obesity in many tissues of mice on a keto diet, regardless of saturated fat levels.
Scientists observed an increase in the levels of bad LDL cholesterol, a major risk factor for heart disease, in mice on a keto diet. Additionally, previous studies have linked the keto diet to kidney stone formation and fractures in kidney patients.
What’s fascinating is that the study found that returning mice to a balanced diet reduced side effects and reversed keto-induced cell senescence. However, the long-term effects in humans are still unknown because most of these studies are short-term.
Another problem is that ketogenic diets can change metabolism. In this study, keto mice showed signs of metabolic disorders, including hypoglycemia. It can affect blood sugar control.
Lastly, the human data from the study suggests that the negative effects of keto might become more pronounced over time. Plasma samples from people on a keto diet for 180 days showed a sharper rise in inflammatory markers compared to those on keto for only 90 days. What it highlights in the end is that there’s definitely more research that needs to be conducted regarding metabolism within the human subjects in the long-term before we can come to a definitive conclusion on the keto diet.
Credits: canva
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a fresh alert for people taking Ozempic, Wegovy, Rybelsus, or Mounjaro. The agency posted a message on social media urging anyone who has experienced a severe reaction to GLP-1 medicines to report it.
According to the UK government’s health site, GLP-1 receptor agonists (glucagon-like peptide-1) are drugs designed to mimic a natural hormone that helps control appetite after eating. While these medicines are widely used for managing diabetes and aiding weight loss, they may also carry certain health risks.
The MHRA’s advisory highlights the importance of reporting side effects, particularly acute pancreatitis, to help researchers understand these reactions and improve drug safety in the future.
Their statement read: “Has someone you care for had a severe reaction to a GLP-1 medicine? Help identify people at risk. Has someone you care for had acute pancreatitis while taking a GLP-1 medicine (Ozempic, Wegovy, Rybelsus, Mounjaro)? You can report it to Yellow Card on their behalf and agree to be contacted. They may be invited to join the Yellow Card Biobank (MHRA and Genomics England) to help researchers study how genetics may influence side effects—leading to safer prescribing in the future.”
The findings from this initiative are expected to help doctors tailor prescriptions to individuals’ genetic profiles, reducing the chances of harmful side effects.
GLP-1 medicines, which is short for glucagon-like peptide-1 receptor agonists mimic a hormone naturally released in the gut after eating. This hormone signals the pancreas to release insulin, which helps move sugar from the blood into the cells for energy.
These drugs also act on the brain to reduce hunger and slow down how quickly the stomach empties, keeping you full for longer. As a result, they can support weight loss and help regulate blood sugar levels, making them a common treatment for type 2 diabetes.
In recent years, the FDA has also approved some GLP-1 drugs for weight loss in people who are overweight or obese, even if they don’t have diabetes. However, for weight management, these medicines are usually prescribed at higher doses than those used to treat diabetes, according to Harvard Health.
There have been reports of pancreatitis, which is inflammation of the pancreas, among some people using GLP-1 drugs. However, current evidence does not show a direct cause-and-effect relationship between these medications and pancreatitis.
In clinical trials, a few participants developed pancreatitis while taking Mounjaro, but such cases were rare. This makes it difficult to determine whether the medication itself was responsible. Similar cases were also seen among people taking other diabetes drugs, suggesting that the link may not be specific to GLP-1 medicines.
It’s also important to note that pancreatitis can occur for several other reasons, including:
So, even if a person on weight loss drugs develops pancreatitis, the medication may not necessarily be the cause.
If you develop symptoms of pancreatitis while using any GLP-1 drug, seek immediate medical attention.
Common signs include:
Always talk to your healthcare provider before starting, stopping, or changing any medication.
With a massive population already living with dementia worldwide, the condition has emerged as one of the leading causes of disability and dependence among older adults. According to the World Health Organization (WHO), dementia is the seventh leading cause of death globally and the number of cases is expected to triple by 2050. Despite its rising prevalence, many people remain unaware of its early symptoms, often mistaking them for normal signs of ageing leading to delayed diagnosis and intervention.
Dementia is an umbrella term for a group of disorders that affect memory, thinking, language and daily functioning. It is not a single disease but a set of symptoms caused by various conditions that damage brain cells. While Alzheimer’s disease is the most common cause, other types include vascular dementia, Lewy body dementia, and frontotemporal dementia (FTD).
Also Read: Can TikTok’s ‘Potato Bed’ Hack Really Help You Sleep Better? Experts Are Not So Sure
There are several risk factors that can increase the likelihood of developing dementia, including age, hypertension, diabetes, obesity, smoking, alcohol consumption and even depression. Though there is no known cure, timely diagnosis and appropriate medical support can significantly improve the quality of life for patients and their families.
Experts emphasise that timely intervention is crucial. With proper care, cognitive therapies and medications, doctors can help people living with dementia function more independently and slow down the progression of symptoms. Unfortunately, the early warning signs are often subtle and easy to dismiss as harmless forgetfulness or stress-related behaviour. Recognising them early can make a world of difference.
Also Read: Popcorn Brain: Is This Syndrome Behind Your Difficulty Concentrating? Experts Explain
1. Misplacing items frequently
Occasionally forgetting where you kept your keys or glasses is normal. But if someone repeatedly misplaces items in unusual places—like finding their glasses in the fridge or cleaning supplies in the kitchen cabinet—it may be an early sign of dementia. This behaviour reflects disorientation and short-term memory loss, both hallmark symptoms.
2. Communication difficulties
A person who was once fluent and articulate may begin to struggle with forming sentences, finding the right words, or following conversations. This can be particularly evident in frontotemporal dementia (FTD), which affects the brain’s frontal and temporal lobes—areas responsible for language and behaviour.
3. Memory lapses
Forgetting recent events, appointments, or names of familiar people can be a red flag. While mild forgetfulness can be age-related, persistent memory issues that interfere with daily life should prompt a visit to a doctor.
4. Sudden mood or personality changes
A calm, even-tempered person becoming irritable, anxious, or tearful without any clear reason could be experiencing early emotional changes associated with dementia. Caregivers often notice these subtle shifts before cognitive symptoms become obvious.
5. Confusion about time or place
Getting lost on familiar routes, forgetting where one is, or confusing family members are significant warning signs. Such disorientation can escalate quickly and pose safety risks if ignored.
While dementia is most common in people over 65, doctors are observing younger-onset cases, especially with FTD, which can develop in individuals as young as 45. Because the symptoms like personality and behaviour changes, mimic psychiatric conditions such as schizophrenia or aphasia, diagnosis is often delayed.
There’s currently no cure for dementia, but early diagnosis can help manage symptoms effectively, plan care better and support families emotionally and financially. If you notice repeated forgetfulness, communication issues or behavioural changes in a loved one, it’s best to consult a doctor or neurologist at the earliest. Awareness, empathy and timely medical attention can go a long way in helping those affected live with dignity and support.
Credits: CANVA
People taking one of Britain’s most widely prescribed painkillers have been reminded by the NHS to watch for serious side effects that should be reported to a doctor right away.** Gabapentin, available only by prescription, is mainly used to treat nerve-related pain caused by conditions such as diabetes, epilepsy, shingles, and restless legs syndrome.
Restless Legs Syndrome (RLS) is a common condition across the UK. It’s estimated that around 10% of adults experience it, and about 2% deal with uncomfortable symptoms nearly every night. This means roughly 2.2 million people in the UK are likely to live with RLS at some point.
Medicines used to treat RLS include alpha-2-delta ligands, such as pregabalin and gabapentin. The specific drug and dosage vary depending on how severe the symptoms are and whether other health conditions are present. In some cases, long-term treatment may be needed.
Gabapentin is among the most frequently prescribed medications in Britain. It is available in tablet, capsule, and liquid forms, and can be taken by most adults and by children aged six and older. While the majority of users do not experience side effects, a small number of people report certain reactions.
According to the NHS, “Like all medicines, gabapentin can cause side effects, although not everyone gets them. These common side effects of gabapentin may happen in more than one in 100 people. They’re usually mild and go away by themselves.”
Some people may experience more serious side effects, such as thoughts of self-harm, swollen glands that do not go away, or persistent stomach pain, which can signal inflammation of the pancreas. The NHS emphasizes that these reactions are rare.
Using gabapentin for an extended period may, in rare instances, lead to dependence, so regular medical supervision is advised while taking this medication.
The prescribed dose of gabapentin depends on the condition being treated. For adults and older children (aged 12 and above), the usual dosage ranges from 900 mg to 3,600 mg per day, divided into three doses.
For younger children under 12, a doctor will determine the right amount based on the child’s body weight.
Doctors may recommend an alternative to gabapentin in some situations, such as:
Speaking to a doctor before starting or adjusting gabapentin is essential to ensure the treatment is safe and effective for each individual.
© 2024 Bennett, Coleman & Company Limited